SEARCH RESULTS

2 RESULTS

Jorg Schulz on Aducanumab Approved to Treat Alzheimer’s Disease

COMMENT The approval and the way of the approval (accelerated approval pathway) comes as a surprise to me. It certainly is driven by political motivation, not by overwhelmingly convincing data. However, for the AD community—patients, relatives, researchers, ...

Current Filters

  • TYPE: Comment x
  • Commentator: Schulz, Jorg x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE